Hangzhou Tigermed Consulting Co., Ltd (HKG:3347)
46.54
-0.04 (-0.09%)
Oct 31, 2025, 4:08 PM HKT
HKG:3347 Market Cap
HKG:3347 has a market cap or net worth of 53.6 billion as of October 31, 2025. Its market cap has decreased by -12.62% in one year.
Market Cap
53.60B
Enterprise Value
57.51B
Revenue
7.17B
Ranking
n/a
PE Ratio
80.12
Stock Price
46.54
Market Cap Chart
Since August 17, 2012, HKG:3347's market cap has increased from 2.44B to 53.60B, an increase of 2,097.49%. That is a compound annual growth rate of 26.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 53.63B | 14.84% |
| Dec 31, 2024 | 46.70B | -5.40% |
| Dec 29, 2023 | 49.36B | -50.14% |
| Dec 30, 2022 | 98.99B | -22.60% |
| Dec 31, 2021 | 127.90B | -22.92% |
| Dec 31, 2020 | 165.93B | 213.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 269.73B |
| Hansoh Pharmaceutical Group Company | 209.22B |
| JD Health International | 199.13B |
| WuXi Biologics | 149.43B |
| Innovent Biologics | 144.96B |
| Sino Biopharmaceutical | 125.85B |
| Akeso | 105.01B |
| Sichuan Kelun-Biotech Biopharmaceutical | 98.36B |